BDBM477071 N-(6-(2H-1,2,3-triazol-2-yl)-5- (trifluoromethyl)pyridin-3-yl)-1- (8-fluoroimidazo[1,2-a]pyridin-5- yl)-5-(trifluoromethyl)-1H- pyrazole-4-carboxamide::US10888550, Compound 4

SMILES Fc1ccc(-n2ncc(C(=O)Nc3cnc(c(c3)C(F)(F)F)-n3nccn3)c2C(F)(F)F)n2ccnc12

InChI Key InChIKey=PZCNEYMDDYPJGE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 477071   

TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM477071(US10888550, Compound 4 | N-(6-(2H-1,2,3-triazol-2-...)
Affinity DataIC50: 50nMAssay Description:MALT1 protease activity was assessed in an in vitro assay using a tetrapeptide as substrate and full-length MALT1 protein (Strep-MALT1(1-824)-His) pu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2021
Entry Details
US Patent